RecruitingNCT07657234
High-intensity tDCS safety and feasibility for late-life depression
About this title
Read the official source — NCT07657234Device studyAges 60+United States
Understand this study
Who could participate?
Listed age limits: from 60 years.
- Listed locations
- DallasSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: October 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 20
- Sponsor
- Andre Russowsky Brunoni
- Sponsor type
- Unknown or unclear
- Study type
- Device
- Intervention type
- Device
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- Over 60 Years
- Official registry ID
- NCT07657234
- Official title
Show the full official title
High-Dose Spaced Bilateral tDCS for Late-Life Depression: Open-Label Pilot Study
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Dallas
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Andre Russowsky Brunoni.
Who can participate?
Listed age limits: from 60 years.
Is this study still recruiting?
The registry lists this study as recruiting.
